FDA approves Intrarosa for postmenopausal women experiencing pain during sex - FDA Press Releases

The U.S. Food and Drug Administration approved Intrarosa (prasterone) to treat women experiencing moderate to severe pain during sexual intercourse (dyspareunia), a symptom of vulvar and vaginal atrophy (VVA), due to menopause. Intrarosa is the first FDA approved product containing the active ingredient prasterone, which is also known as dehydroepiandrosterone (DHEA).

from Food and Drug Administration--Press Releases http://ift.tt/2eJEqA9
via IFTTT